Literature DB >> 35118134

Disfiguring Hidradenitis Suppurativa of the Face.

Gianmarco Capasso1, Gabriella Fabbrocini1, Claudio Marasca1.   

Abstract

INTRODUCTION: Hidradenitis suppurativa (HS) is a chronic, disfiguring, and debilitating inflammatory skin condition accompanied by pain, malodorous discharge, scarring, and a scarce quality of life. Skin folds are the most frequently affected areas, while the face is rarely involved. CASE
PRESENTATION: We herein report a case of a man in his 40s affected by a severe form of HS for 15 years. Physical examination showed massive, bridged scarring located on the cheeks, temporal area, chin, nuchae, and scalp. DISCUSSION: Massive face scarring due to HS is an infrequent event and represents a further burden for patients affected by HS and a therapeutic challenge for clinicians due to the lack of codified guidelines. Novel therapies with lasers and combination therapies are emerging and may be beneficial for hypertrophic scarring in HS.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Hidradenitis suppurativa; Hypertrophic scars; Laser; Quality of life

Year:  2021        PMID: 35118134      PMCID: PMC8787590          DOI: 10.1159/000518433

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  10 in total

Review 1.  Hidradenitis suppurativa: pathogenesis and management.

Authors:  D E M Slade; B W Powell; P S Mortimer
Journal:  Br J Plast Surg       Date:  2003-07

Review 2.  The Handicap of Hidradenitis Suppurativa.

Authors:  Inge Elizabeth Deckers; Alexa Boer Kimball
Journal:  Dermatol Clin       Date:  2015-09-14       Impact factor: 3.478

3.  Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa.

Authors:  J Boer; M J van Gemert
Journal:  J Am Acad Dermatol       Date:  1999-01       Impact factor: 11.527

4.  Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.

Authors:  G Fabbrocini; C Marasca; M Megna; K Peris
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-10       Impact factor: 6.166

5.  Efficacy of fractional CO2 laser with intralesional steroid compared with intralesional steroid alone in the treatment of keloids and hypertrophic scars.

Authors:  Sajin Alexander; Banavasi S Girisha; Handattu Sripathi; Tonita M Noronha; Akshata C Alva
Journal:  J Cosmet Dermatol       Date:  2019-02-15       Impact factor: 2.696

6.  Back and face involvement in hidradenitis suppurativa.

Authors:  Florence Poli; Pierre Wolkenstein; Jean Revuz
Journal:  Dermatology       Date:  2010-07-05       Impact factor: 5.366

7.  Residual scarring from hidradenitis suppurativa: fractionated CO2 laser as a novel and noninvasive approach.

Authors:  Andrew C Krakowski; Shehla Admani; Nathan S Uebelhoer; Lawrence F Eichenfield; Peter R Shumaker
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

8.  Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

Authors:  Florence Canoui-Poitrine; Jean E Revuz; Pierre Wolkenstein; Cédric Viallette; Germaine Gabison; Florence Pouget; Florence Poli; Ousmane Faye; Sylvie Bastuji-Garin
Journal:  J Am Acad Dermatol       Date:  2009-04-29       Impact factor: 11.527

Review 9.  Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: a review of the literature.

Authors:  Claudio Marasca; Gabriella Fabbrocini; Luigi Barrea; Gianmarco Capasso; Adriana DI Guida; Eleonora Cinelli; Giuseppina Fontanella
Journal:  Minerva Endocrinol       Date:  2020-09-24       Impact factor: 2.184

10.  Quality of life in people living with patients suffering from hidradenitis suppurativa.

Authors:  C Marasca; M Napolitano; G Monfrecola; A Masarà; M C Annunziata; M Donnarumma; G Fabbrocini
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-27       Impact factor: 6.166

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.